Pictet-Health PUSD
Sub-fund of Pictet (SICAV domiciled in Luxembourg)
Key Information
Legal Documents
Performance
Analysis

Fund Profile

Category: SICAV

OBJECTIVE
To increase the value of your investment.
PORTFOLIO ASSETS
The Compartment mainly invests in equities of companies that are active in sectors related to health. The Compartment may invest worldwide, including in emerging markets and Mainland China.
DERIVATIVES AND STRUCTURED PRODUCTS
The Compartment may use derivatives to reduce various risks (hedging) and for efficient portfolio management, and may use structured products to gain exposure to portfolio assets.
COMPARTMENT CURRENCY
USD
INVESTMENT PROCESS
In actively managing the Compartment, the investment manager uses a combination of market and fundamental company analysis to select securities that it believes offer favourable growth prospects at a reasonable price.

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Risk and reward profile
6
Lower Risk
Possible Lower
Returns
Higher Risk
Possible Higher
Returns
Key Information
Closing Price 13/12/2019301.24
Morningstar categorySector Equity Healthcare
CurrencyUSD
Distribution statusAccumulating
ISINLU0188501257
Inception Date30/06/2004
Minimum initial amount100.00 USD
Fees And Charges
Entry feeNone
Purchase charge0.5% (subject to minimum)
Custody feeNone
Exit feeNone
Sale chargeNone
Ongoing charge2.02% of which 0.80% is paid by the Fund Manager to MeDirect
Fund management company
AddressPictet Asset Management (Europe) SA 15, avenue J.F. Kennedy Luxembourg L-1855 Luxembourg
Manager NameGrégoire Biollaz
Manager Start Date01/04/2016
Websitewww.am.pictet
Total Net Assets (mil)523.91 USD (30/11/2019)
UCITSYes
AdministratorFundPartner Solutions (Europe) S.A.

Legal Documents

Prospectus
en 01/10/2019
Annual Report
en 30/09/2019
Semi Annual Report
en 31/03/2019
Morningstar Report
15/12/2019

Performance

Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
The performance in euro can be lower or higher than the performance in the currency of denomination of the fund due to fluctuations in exchange rates.
Annualised performance in USD
PeriodAnnualised returnDate
1 year12.43%13/12/2019
3 years11.05%13/12/2019
5 years3.85%13/12/2019
10 years9.51%13/12/2019
Since launch7.40%13/12/2019
Cumulative performance in USD
Performance
YTD 01/01/201920.29%
1 month3.41%
3 months6.74%
6 months7.96%
Quarterly Returns
Q 1Q 2Q 3Q 4
201911.14%1.61%-1.91%-
2018-1.39%5.15%11.70%-14.15%
20178.96%5.70%2.20%-2.22%
2016-7.75%3.63%-0.36%-7.74%
20159.57%1.26%-12.84%2.99%
Dividend
No Data Available

Asset Allocation
% Long% Short% Net Assets
Stock95.86%0.00%95.86%
Bond0.00%0.00%0.00%
Cash4.42%0.28%4.14%
Other0.00%0.00%0.00%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
16.5913.2414.08
Sharpe Ratio
0.470.750.22
Sortino Ratio
0.741.130.30
Positive Months7.0024.0034.00
Negative Months5.0012.0026.00
Worst Month-9.28-9.28-9.85
World Regions
Region%
United States62.86
Europe - ex Euro13.83
Eurozone8.64
United Kingdom5.04
Japan3.45
Asia - Developed2.04
Stock Sector Weighting
Sector% of Equity
Healthcare61.16
Consumer Defensive12.79
Consumer Cyclical8.49
Industrials7.47
Basic Materials3.91
Technology2.04
Top 10 Holdings
HoldingSectorCountry% of Assets
UnitedHealth Group Inc HealthcareUnited States5.10
Roche Holding AG Dividend Right Cert. HealthcareSwitzerland5.01
Abbott Laboratories HealthcareUnited States4.26
Thermo Fisher Scientific Inc HealthcareUnited States4.17
Unilever NV Consumer DefensiveNetherlands3.56
Boston Scientific Corp HealthcareUnited States3.52
Merck & Co Inc HealthcareUnited States3.44
Quest Diagnostics Inc HealthcareUnited States3.32
Eli Lilly and Co HealthcareUnited States2.98
Waste Management Inc IndustrialsUnited States2.77
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
$
301.24
Closing Price
All key information and documents must be reviewed before being able to Invest.